LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase

Yuchang Fu1, Yan Huang, Sumita Bandyopadhyay

  • 1Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC 29401, USA.

Insights

Low-density lipoprotein-containing immune complexes (LDL-ICs) increase LDL receptor (LDLR) expression in macrophages. This occurs through the ERK signaling pathway and AP-1 transcription factor activation, not sterol-regulatory element binding proteins.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Low-density lipoprotein-containing immune complexes (LDL-ICs) are known to up-regulate LDL receptor (LDLR) expression in human macrophages.
  • Understanding the precise molecular mechanisms and signaling pathways involved is crucial for elucidating cellular lipid metabolism and immune responses.

Purpose of the Study:

  • To investigate the molecular mechanisms by which LDL-ICs up-regulate LDLR expression.
  • To identify the specific signaling pathways mediating LDLR up-regulation induced by LDL-ICs.

Main Methods:

  • Treatment of U937 histiocytes with LDL-ICs.
  • Analysis of sterol-regulatory element binding proteins (SREBPs) precursors and cleaved forms.
  • Promoter deletion and mutation studies for LDLR gene.
  • Electrophoretic mobility shift assays (EMSA) to assess transcription factor activity.
  • Investigation of extracellular signal-regulated kinase (ERK) signaling pathway.

Main Results:

  • LDL-ICs did not alter SREBP-1a or SREBP-2 levels, suggesting SREBPs are not involved in this process.
  • AP-1 binding sites in the LDLR promoter were essential for LDL-IC-stimulated expression.
  • LDL-ICs enhanced AP-1 transcription factor activity.
  • LDLR up-regulation by LDL-ICs was dependent on the ERK signaling pathway.

Conclusions:

  • LDL-ICs up-regulate LDLR expression in macrophages.
  • The mechanism involves ERK signaling pathway activation.
  • Transcriptional activation is mediated through AP-1 motifs.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Inflammation01:38

Inflammation

Overview
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...